1. The EV antibody database: An interactive database of curated antibodies for extracellular vesicle and nanoparticle research
- Author
-
Amber Morey, Martin Ng, Michail Spanos, Piyan Zhang, Tuoye Xu, Willi Cheung, Emeli Chatterjee, Priyanka Gokulnath, Natacha Carnel-Amar, Ana Luisa Soares Chiaretti, Collin Nelson, Jubin George, Michelle Luo, Abhik Chakraborty, Luiza Perucci, Jennifer C. Jones, Peter De Hoff, Jeffrey L. Franklin, Robert L. Raffai, Saumya Das, David A. Routenberg, John P. Nolan, Al Charest, Louise C. Laurent, and Roger P. Alexander
- Subjects
Extracellular vesicles ,Nanoparticles ,Exosomes ,Antibody database ,Antibodies ,Biology (General) ,QH301-705.5 ,Medicine (General) ,R5-920 - Abstract
Antibodies are critical tools for research into extracellular vesicles (EVs) and other extracellular nanoparticles (ENPs), where they can be used for their identification, characterization, and isolation. However, the lack of a centralized antibody platform where researchers can share validation results thus minimizing wasted personnel time and reagents, has been a significant obstacle. Moreover, because the performance of antibodies varies among assay types and conditions, detailed information on assay variables and protocols is also of value. To facilitate sharing of results on antibodies that are relevant to EV/ENP research, the EV Antibody Database has been developed by the investigators of the Extracellular RNA Communication Consortium (ERCC). Hosted by the ExRNA Portal (https://exrna.org/resources/evabdb/), this interactive database aggregates and shares results from antibodies that have been tested by research groups in the EV/ENP field. Currently, the EV Antibody Database includes modules for antibodies tested for western Blot, EV Flow Cytometry, and EV Sandwich Assays, and holds 110 records contributed by 6 laboratories from the ERCC. Detailed information on antibody sources, assay conditions, and results is provided, including negative results. We encourage ongoing expert input and community feedback to enhance the database's utility, making it a valuable resource for comprehensive validation data on antibodies and protocols in EV biology.
- Published
- 2024
- Full Text
- View/download PDF